| Financial Year |
March 31 2023 |
| Monetary Funds |
73,720,870,739.36 |
| Held-for-trading Financial Assets |
48,070,924,762.23 |
| Notes Receivable |
19,665,731.99 |
| Accounts Receivable |
371,082,690.28 |
| Advances to Suppliers |
158,887,547.98 |
| Other Receivables |
1,400,504,797.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
127,090,735,894.77 |
| Other Current Assets |
15,442,412,790.99 |
| Total Current Assets |
272,575,236,325.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
88,329,826,840.22 |
| Long-term Equity Investment |
7,784,426,625.27 |
| Investment Properties |
2,281,587,540.14 |
| Fixed Assetes |
19,253,507,543.07 |
| Under-construction Projects |
532,713,528.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
176,805,607.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
26,086,749.14 |
| Deferred Income Tax Assets |
3,173,697,042.15 |
| Other Non-Current Assets |
2,105,326,102.08 |
| Sub-Total of Non-Current Assets |
175,807,688,560.84 |
| Total Assets |
448,382,924,886.28 |
| Short-Term Loans |
54,596,080,718.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,212,428,000.00 |
| Accounts Payable |
306,663,820.58 |
| Accounts Received In Advance |
917,359,741.23 |
| Employee Compensation Payable |
158,299,097.41 |
| Taxes Payable |
1,316,445,924.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,227,805,408.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
28,280,608,921.56 |
| Other Current Liabilities |
9,216,671,886.18 |
| Sub-Total of Current Liabilities |
274,146,205,129.71 |
| Long-term Loans |
41,810,906,231.01 |
| Bonds Payable |
46,543,374,512.34 |
| Long-Term Accounts Payable |
5,852,752,136.68 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,922,630,817.48 |
| Other Non-Current Liabilities |
2,603,290,883.66 |
| Sub-Total of Non-Current Liabilities |
104,871,006,496.86 |
| Total Liabilities |
379,017,211,626.57 |
| Paid-In Capital(Or Share Stock) |
8,830,692,012.00 |
| Capital Surplus |
5,514,679,480.55 |
| Surplus Reserve |
1,009,331,703.31 |
| LESS:Treasury Stock |
143,658,571.37 |
| Undistributed Profits |
16,068,265,716.08 |
| Minority Stockholder's Interest |
29,101,998,140.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
40,263,715,118.80 |
| Owner's Equity（Stockholder's Equity） |
69,365,713,259.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
448,382,924,886.28 |
